FAP and neoplasm: FAP has been targeted in tumors for imaging and therapy using several approaches, including immunoconjugates (an antibody–maytansinoid conjugate (mAb FAP5-DM1)), CAR T cells, tumor immunotherapy, vaccines, peptide drug complexes, FAP inhibitors, and antibodies [87,88,89].